Brief: Allergy Therapeutics Says Group Extended Cash Runway Towards End Of Jan 2024
11/12/2023 07:43
Dec 11 (Reuters) - Allergy Therapeutics PLC AGY.L :
* UPDATE ON FUNDING
* SALES FOR FY TO 30 JUNE 2024 EXPECTED TO BE SLIGHTLY LOWER
THAN
COMPARABLE PERIOD
* GROUP EXTENDED ITS CASH RUNWAY TOWARDS END OF JANUARY 2024
Source text for Eikon: ID:nRSK2524Wa
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman